Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction?

Bibliographic Details
Main Authors:	Anke C. Fender, Dobromir Dobrev
Format:	Article
Language:	English
Published:	Elsevier 2020-04-01
Series:	International Journal of Cardiology: Heart & Vasculature
Subjects:	Ticagrelor Clopidogrel P2Y12 Bleeding Myocardial infarction
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352906720300737

id	doaj-da74db641d764420a4262042916c564b
record_format	Article
spelling	doaj-da74db641d764420a4262042916c564b2020-11-25T02:51:08ZengElsevierInternational Journal of Cardiology: Heart & Vasculature2352-90672020-04-0127Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction?Anke C. Fender0Dobromir Dobrev1Corresponding author at: Institute of Pharmacology, Medical Faculty, University Duisburg-Essen, Hufelandstr. 55, 45122 Essen, Germany.; Institute of Pharmacology, Medical Faculty, University Duisburg-Essen, GermanyInstitute of Pharmacology, Medical Faculty, University Duisburg-Essen, Germanyhttp://www.sciencedirect.com/science/article/pii/S2352906720300737TicagrelorClopidogrelP2Y12BleedingMyocardial infarction
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Anke C. Fender Dobromir Dobrev
spellingShingle	Anke C. Fender Dobromir Dobrev Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction? International Journal of Cardiology: Heart & Vasculature Ticagrelor Clopidogrel P2Y12 Bleeding Myocardial infarction
author_facet	Anke C. Fender Dobromir Dobrev
author_sort	Anke C. Fender
title	Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction?
title_short	Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction?
title_full	Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction?
title_fullStr	Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction?
title_full_unstemmed	Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction?
title_sort	pleiotropic actions of ticagrelor versus clopidogrel – do molecular differences translate into superior clinical efficacy after myocardial infarction?
publisher	Elsevier
series	International Journal of Cardiology: Heart & Vasculature
issn	2352-9067
publishDate	2020-04-01
topic	Ticagrelor Clopidogrel P2Y12 Bleeding Myocardial infarction
url	http://www.sciencedirect.com/science/article/pii/S2352906720300737
work_keys_str_mv	AT ankecfender pleiotropicactionsofticagrelorversusclopidogreldomoleculardifferencestranslateintosuperiorclinicalefficacyaftermyocardialinfarction AT dobromirdobrev pleiotropicactionsofticagrelorversusclopidogreldomoleculardifferencestranslateintosuperiorclinicalefficacyaftermyocardialinfarction
_version_	1724736110063517696

Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction?

Similar Items